JP2007513118A - ビスホスホネートの医薬的使用 - Google Patents

ビスホスホネートの医薬的使用 Download PDF

Info

Publication number
JP2007513118A
JP2007513118A JP2006541901A JP2006541901A JP2007513118A JP 2007513118 A JP2007513118 A JP 2007513118A JP 2006541901 A JP2006541901 A JP 2006541901A JP 2006541901 A JP2006541901 A JP 2006541901A JP 2007513118 A JP2007513118 A JP 2007513118A
Authority
JP
Japan
Prior art keywords
bisphosphonate
chemotherapeutic agent
letrozole
trail
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006541901A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007513118A5 (https=
Inventor
ロバート・エドワード・コールマン
イングン・ホレン
ヘレン・ネビル−ウェブ
キャサリン・アリソン・エバンズ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sheffield
Original Assignee
University of Sheffield
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sheffield filed Critical University of Sheffield
Publication of JP2007513118A publication Critical patent/JP2007513118A/ja
Publication of JP2007513118A5 publication Critical patent/JP2007513118A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2006541901A 2003-12-03 2004-12-02 ビスホスホネートの医薬的使用 Pending JP2007513118A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0328040.1A GB0328040D0 (en) 2003-12-03 2003-12-03 Pharmaceutical uses of bisphosphonates
PCT/EP2004/013728 WO2005053709A2 (en) 2003-12-03 2004-12-02 Pharmaceutical uses of bisphosphonates

Publications (2)

Publication Number Publication Date
JP2007513118A true JP2007513118A (ja) 2007-05-24
JP2007513118A5 JP2007513118A5 (https=) 2008-01-24

Family

ID=29764511

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006541901A Pending JP2007513118A (ja) 2003-12-03 2004-12-02 ビスホスホネートの医薬的使用

Country Status (11)

Country Link
US (1) US20070219115A1 (https=)
EP (1) EP1691816A2 (https=)
JP (1) JP2007513118A (https=)
KR (1) KR20060130052A (https=)
CN (2) CN101669958A (https=)
AU (1) AU2004294713B2 (https=)
BR (1) BRPI0417218A (https=)
CA (1) CA2546782A1 (https=)
GB (1) GB0328040D0 (https=)
RU (1) RU2006123423A (https=)
WO (1) WO2005053709A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2332636B1 (es) * 2008-08-06 2011-02-10 Universitat De Les Illes Balears Composicion de liquido de dialisis.
WO2011133687A2 (en) * 2010-04-20 2011-10-27 President And Fellows Of Harvard College Methods and compositions for inhibition of beta2-adrenergic receptor degradation
CN102961785A (zh) * 2012-11-09 2013-03-13 于秀淳 一种用于治疗骨巨细胞瘤的瘤腔填充物及其制备方法
AU2018445164B2 (en) 2018-10-11 2025-05-29 Vifor (International) Ltd. Inositol phosphates for the treatment of ectopic calcification

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002536414A (ja) * 1999-02-10 2002-10-29 アストラゼネカ アクチボラグ 血管形成阻害剤としてのキナゾリン誘導体
WO2003035081A1 (en) * 2001-10-19 2003-05-01 Novartis Ag Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003250190A1 (en) * 2002-07-30 2004-02-23 Novartis Ag Combination of an aromatase inhibitor with a bisphosphonate

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002536414A (ja) * 1999-02-10 2002-10-29 アストラゼネカ アクチボラグ 血管形成阻害剤としてのキナゾリン誘導体
WO2003035081A1 (en) * 2001-10-19 2003-05-01 Novartis Ag Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol

Also Published As

Publication number Publication date
BRPI0417218A (pt) 2007-02-21
EP1691816A2 (en) 2006-08-23
WO2005053709A2 (en) 2005-06-16
CN101669958A (zh) 2010-03-17
WO2005053709A3 (en) 2006-01-05
US20070219115A1 (en) 2007-09-20
AU2004294713A1 (en) 2005-06-16
RU2006123423A (ru) 2008-01-20
CA2546782A1 (en) 2005-06-16
AU2004294713B2 (en) 2009-04-30
CN1889962A (zh) 2007-01-03
KR20060130052A (ko) 2006-12-18
GB0328040D0 (en) 2004-01-07

Similar Documents

Publication Publication Date Title
TWI275393B (en) Use of bisphosphonates for pain treatment
RU2297229C2 (ru) Фармацевтическое применение бисфосфонатов
US20090209493A1 (en) Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
AU2002257802A1 (en) Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer
JP2006506365A (ja) ビスホスホネートの投与方法
JP2011057706A (ja) アロマターゼ阻害剤とビスホスホネートの組み合わせ
AU2004294713B2 (en) Pharmaceutical uses of bisphosphonates
AU2002363089B2 (en) Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a COX-2 inhibitor and a taxol
AU2002363089A1 (en) Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a COX-2 inhibitor and a taxol
MXPA06006278A (en) Pharmaceutical uses of bisphosphonates
HK1080734B (en) Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
HK1080733B (en) Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates,a cox-2 inhibitor and a taxol

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071127

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071127

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110830